254 related articles for article (PubMed ID: 21850418)
1. Widespread use of neuraminidase inhibitors in Japan.
Sugaya N
J Infect Chemother; 2011 Oct; 17(5):595-601. PubMed ID: 21850418
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
4. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
5. The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.
Hirotsu N; Saisho Y; Hasegawa T
Influenza Other Respir Viruses; 2019 Mar; 13(2):123-132. PubMed ID: 29989680
[TBL] [Abstract][Full Text] [Related]
6. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
[TBL] [Abstract][Full Text] [Related]
7. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
Ikematsu H; Kawai N; Kashiwagi S
J Infect Chemother; 2012 Aug; 18(4):529-33. PubMed ID: 22370919
[TBL] [Abstract][Full Text] [Related]
8. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of influenza resistance to the neuraminidase inhibitors.
Thorlund K; Awad T; Boivin G; Thabane L
BMC Infect Dis; 2011 May; 11():134. PubMed ID: 21592407
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
Kawai N; Ikematsu H; Tanaka O; Matsuura S; Maeda T; Yamauchi S; Hirotsu N; Nishimura M; Iwaki N; Kashiwagi S
J Infect Chemother; 2011 Jun; 17(3):375-81. PubMed ID: 21120678
[TBL] [Abstract][Full Text] [Related]
11. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
[TBL] [Abstract][Full Text] [Related]
12. Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
Kawai N; Ikematsu H; Kawashima T; Maeda T; Ukai H; Hirotsu N; Iwaki N; Kashiwagi S
Influenza Other Respir Viruses; 2013 May; 7(3):448-55. PubMed ID: 22897904
[TBL] [Abstract][Full Text] [Related]
13. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
Mawatari M; Saito R; Hibino A; Kondo H; Yagami R; Odagiri T; Tanabe I; Shobugawa Y;
PLoS One; 2019; 14(11):e0224683. PubMed ID: 31697721
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
16. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children.
Sugaya N; Shinjoh M; Mitamura K; Takahashi T
J Infect; 2011 Oct; 63(4):288-94. PubMed ID: 21722665
[TBL] [Abstract][Full Text] [Related]
17. Influenza viruses resistant to neuraminidase inhibitors.
Nitsch-Osuch A; Brydak LB
Acta Biochim Pol; 2014; 61(3):505-8. PubMed ID: 25195142
[TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012-2013.
Takemoto Y; Asai T; Ikezoe I; Yano T; Ichikawa M; Miyagawa S; Matsumoto J
Chemotherapy; 2013; 59(5):373-8. PubMed ID: 24821568
[TBL] [Abstract][Full Text] [Related]
20. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection.
Sugaya N; Ohashi Y
Antimicrob Agents Chemother; 2010 Jun; 54(6):2575-82. PubMed ID: 20368393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
